Form 4: Director Phoebe Yang Increases Stake in GE HealthCare

GE HealthCare Director Phoebe L. Yang acquired 4,586 shares through a combination of an RSU grant and open market purchases.

Summary

• Director Phoebe L. Yang received an award of 3,586 restricted stock units (RSUs) on May 7, 2026.
• The director purchased an additional 1,000 shares of common stock on May 8, 2026, at a weighted average price of $63.0063 per share.
• Following these transactions, the director's total beneficial ownership in GE HealthCare Technologies Inc. increased to 13,702 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as the director's decision to purchase shares with personal capital indicates confidence in the company's future performance.

Positives

• Director demonstrates confidence in the company by purchasing 1,000 shares on the open market.
• Alignment of interests between the director and shareholders through increased equity ownership.

Negatives

• None identified.

Risks

• Market price volatility affecting the value of the director's holdings.

Future Outlook

The RSUs granted are scheduled to vest on the earlier of the next annual meeting of stockholders or May 7, 2027.

Industry Context

StockSavvy.ai notes that director open-market purchases are generally viewed as a positive signal of internal confidence in the company's long-term strategic direction and valuation.

Comparison to Industry Standards

• Director equity accumulation is consistent with standard corporate governance practices for large-cap healthcare technology firms.
• The use of RSU grants for non-employee directors is a standard industry practice for long-term incentive alignment.

Stakeholder Impact

• Positive signal for shareholders regarding management and board confidence.

Next Steps

• Vesting of 3,586 RSUs on or before May 7, 2027.

Key Dates

Keywords

GE HealthCare, GEHC, Insider Trading, Form 4, Director Ownership, Equity Compensation